Skip to content

13F-HR filed by BIOS Capital Management, LP

BIOS Capital Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 20:22:28 UTC, with 6 holding rows worth $34,170,550.

Accession
0001813845-26-000009
Filed
2026-11-13
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 9 entries on the cover page, a total value of $34,170,550 stated on the cover page (in dollars after the unit check, H1), rows summing to $34,170,550 with VALUE read as dollars as filed, 13F file number 028-24868. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OPUS GENETICS INC67577R102COMMON STOCK3,683,429$17,827,796dollars as filed
ACTUATE THERAPEUTICS INC005083100COM10,049,996$7,838,997dollars as filed
COGNITION THERAPEUTICS INC19243B102COM6,000,000$5,760,000dollars as filed
REIN THERAPEUTICS INC00887A204COM NEW2,982,375$2,397,830dollars as filed
LANTERN PHARMA INC51654W101COM235,895$238,254dollars as filed
IN8BIO INC45674E208COM NEW80,957$107,673dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001813845-26-000009this filing2026-11-13